Yuanjun Zheng
Overview
Explore the profile of Yuanjun Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang X, Liu B, Huang J, Zhang Y, Xu N, Gale R, et al.
Blood
. 2024 Jul;
144(18):1951-1961.
PMID: 39046786
Although tyrosine kinase inhibitor (TKI) therapy has markedly improved the survival of people with chronic-phase chronic myeloid leukemia (CML), 20% to 30% of people still experienced therapy failure. Data from...
2.
Bai X, Zhou Z, Zheng Z, Li Y, Liu K, Zheng Y, et al.
BMC Med Inform Decis Mak
. 2024 Jun;
24(1):174.
PMID: 38902714
Introduction: The correlation between radiation exposure before pregnancy and abnormal birth weight has been previously proven. However, for large-for-gestational-age (LGA) babies in women exposed to radiation before becoming pregnant, there...
3.
Zhang X, Xu N, Yang Y, Lin H, Liu B, Du X, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Mar;
24(6):e257-e266.
PMID: 38461040
Background: There are limited data comprehensively comparing therapy responses and outcomes among nilotinib, dasatinib, flumatinib and imatinib for newly diagnosed chronic-phase chronic myeloid leukemia in a real-world setting. Patients And...